ARIA ASSURE RESOURCE FOR INTEGRATED ACCESS
DEAD

Serial Number

87626617

Owner

OTSUKA AMERICA PHARMACEUTICAL, INC.

Attorney

B. Brett Heavner

Filing Date

Sep 28, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ARIA ASSURE RESOURCE FOR INTEGRATED ACCESS Trademark

Serial Number: 87626617

ARIA ASSURE RESOURCE FOR INTEGRATED ACCESS is a trademark filed by OTSUKA AMERICA PHARMACEUTICAL, INC. on September 28, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

OTSUKA AMERICA PHARMACEUTICAL, INC. (74 trademarks)

Entity Type: 03

Trademark Details

Filing Date

September 28, 2017

Registration Date

Not Registered

Published for Opposition

August 21, 2018

Goods & Services

Educational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications in the nature of user guides; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment

Electronic publications, namely, downloadable brochures and pamphlets about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; downloadable video recordings about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment

Printed materials, namely, brochures, pamphlets and posters about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment

Providing financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders

Promoting awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients about health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment

Providing patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 8, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 8, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 28, 2019 EXRA
SOU EXTENSION 2 GRANTED
Sep 26, 2019 EX2G
SOU EXTENSION 2 FILED
Sep 26, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 26, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 12, 2019 EXRA
SOU EXTENSION 1 GRANTED
Apr 10, 2019 EX1G
SOU EXTENSION 1 FILED
Apr 10, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 10, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 16, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 21, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 21, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 1, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 13, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 12, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 12, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 12, 2018 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 5, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2017 NWOS
NEW APPLICATION ENTERED
Oct 2, 2017 NWAP